Implantica

Implantica’s RefluxStop™ makes an impact at the leading Annual European Foregut Society Meeting

by

VADUZ, Liechtenstein, Nov. 15, 2023 /PRNewswire/ — Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces participation in the 3rd Annual EFS (European Foregut Society) Congress in Milan, Italy in early November. The Scientific Program at EFS included the symposium, ‘Reconstruction of the Anti-Reflux Barrier (ARB) with RefluxStop™- an … Read more

Implantica reports that two independent surgeons presented their RefluxStop™ patient data at the 2023 Annual Swiss College of Surgeons Congress (SCS)

by

VADUZ, Liechtenstein, June 15, 2023 /PRNewswire/ — Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, announces that two independent scientific presentations on RefluxStop™ patient data were delivered at the 2023 SCS meeting in Basel in June 7-9, 2023.   RefluxStop™ was featured as part of this year’s … Read more

Implantica Announces Completion of First RefluxStop™ procedures by the President of the European Foregut Society

by

VADUZ, Liechtenstein, June 8, 2023 /PRNewswire/ — Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, announces today that the world-renowned anti-reflux surgeon, Professor Luigi Bonavina from IRCCS Policlinico San Donato Hospital in Milan, Italy completed his first two RefluxStop™ procedures recently. Professor Bonavina is the Head of the University … Read more

Implantica’s RefluxStop™ Wins Medtop Tech’s Most Innovative Device Category Award

by

VADUZ, Liechtenstein, May 30, 2023 /PRNewswire/ — Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, announces today that Medtop recognized RefluxStop™ as the most innovative medical device among all competitors. “We thank Medtop for acknowledging Implantica’s premier commercial product, RefluxStop™, as the most innovative medical device for 2023. … Read more

Bulletin from the Annual General Meeting of Implantica AG

by

VADUZ, Liechtenstein, May 26, 2023 /PRNewswire/ — Today, May 25, 2023, the annual general meeting (the “AGM”) of Implantica AG (publ) was held in Ruggel, Liechtenstein. The general meeting resolved to adopt all of the board of directors’ resolution proposals. A summary of the resolutions adopted at the general meeting is set out below. The general meeting … Read more

Implantica announces that RefluxStop™ results were presented at the DDW Conference in Chicago

by

VADUZ, Liechtenstein, May 16, 2023 /PRNewswire/ — Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, announces that Dr. med. Zehetner, Prof. (USC) from Switzerland, presented Klinik Beau-Site’s RefluxStop™ results at Digestive Disease Week (DDW) 6-9 May, in Chicago, U.S., the world’s premier meeting for gastrointestinal professionals Dr. med. … Read more

Implantica publishes Interim Report January

by

RefluxStop™ – Designed for a Revolution in the Care of Acid Reflux VADUZ, Liechtenstein, May 12, 2023 /PRNewswire/ — Significant events in the first quarter of 2023            RefluxStop™ is currently being launched in Scandinavia, with Ersta Hospital and Sundsvall Sjukhus in Sweden, the first centers committing to join our registry study.          … Read more